Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Coherus
Coherus
Coherus again axes staff, with 30% of roles on chopping block amid 'sharpened focus' on cancer drugs
Fierce Pharma
Thu, 03/14/24 - 11:33 am
Coherus
layoffs
restructuring
Sandoz makes its first post-spinout acquisition
Pharmaphorum
Mon, 01/22/24 - 11:12 am
Sandoz
M&A
Coherus
biosimilars
Biosimilar makers split strategies in bid to take on top-selling Humira
BioPharma Dive
Thu, 07/27/23 - 10:25 am
biosimilars
Humira
AbbVie
rebates
drug pricing
Amgen
Celltrion
Novartis
Boehringer Ingelheim
Biocon
Fresenius
Sandoz
Organon
Coherus
DEAL WATCH: Biosimilars, Biosimilars and More Biosimilars
Big Molecule Watch
Sun, 11/10/19 - 07:55 pm
biosimilars
Henlius
Ascentage
rituximab
Bioeq
Alvotech
Coherus
Biogen
Samsung Bioepis
Coherus looks to disrupt Amgen’s $4B Neulasta franchise as analysts look for a deep discount on its copycat price
Endpoints
Mon, 11/5/18 - 09:56 am
Coherus
Neulasta
Mylan
biosimilars
Amgen
In latest setback, another Coherus partner bails out on Amgen biosimilar deal
Endpoints
Wed, 07/5/17 - 09:37 am
Coherus
Amgen
biosimilars
Daiichi Sankyo
CHS-0214
rheumatoid arthritis
Enbrel